tirzepatide 10 mg/0.5 ml Semaglutide & Dosing Guide: mg to Units Chart ALI-TIRZEP 10MG - Laos Alliance

Eli Lilly intended to protect its tirzepatide patent aggressively, and any entity selling, compounding, or distributing unauthorized versions faced serious legal exposure

Lose 11-20% of your weight with GLP-1s Medication plus the support you need to reach your goals Message your care team whenever, wherever Progress tracking tools On-demand coaching and support Regular check-ins to keep you on track Refills made simple Average weight loss in 1 year is 11-20% (vs ~2-3% with diet and exercise alone)

Genetic predispositions in peptide-pathway genes (such as GLP1R and GIPR variants) may influence how your body responds to GLP-1 therapy

The slowed movement of food through the digestive system prolongs the sensation of fullness after meals

Triglycerides were significantly reduced at all doses of tirzepatide compared to placebo

For more information, contact us today to schedule a consultation online